Last reviewed: 13 Feb 2025
Last updated: 03 Dec 2024
Summary
Definition
History and exam
Key diagnostic factors
- erythromelalgia
- splenomegaly
- arterial and venous thrombosis
- bleeding
- livedo reticularis
Full details
Other diagnostic factors
- age ≥60 years
- female sex
- headache
- dizziness, lightheadedness, chest pain, vertigo, and paresthesia
- syncope and seizures
- transient visual disturbances
- priapism
Full details
Risk factors
- genetic mutations (JAK2 V617F, CALR, or MPL)
- black ethnicity
- age ≥60 years
- female sex
Full details
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- CBC with differential
- peripheral blood smear
- serum iron studies
Detalhes completos
Investigações a serem consideradas
- CRP
- erythrocyte sedimentation rate (ESR)
- fibrinogen
- bone marrow biopsy and histopathology
- genetic mutation testing (JAK2 V617F, CALR, and MPL)
- cytogenetic and molecular testing: BCR::ABL1
Detalhes completos
Algoritmo de tratamento
AGUDA
life-threatening thrombosis, severe thrombocytosis-related neurologic complications, or severe bleeding
CONTÍNUA
nonpregnant: very low-, low-, or intermediate-risk
nonpregnant: high risk
pregnant: very low-, low-, or intermediate-risk
pregnant: high-risk
Colaboradores
Autores
Debabrata Mukherjee, MD, FACC

Chairman, Department of Internal Medicine
Professor of Internal Medicine
Texas Tech University Health Sciences Center at El Paso
El Paso
TX
Declarações
DM declares that he has no competing interests.
Revisores
Tony Kan, MD
Senior Staff Physician
Henry Ford Medical Center
Sterling Heights
MI
Declarações
TK declares that he has no competing interests.
Uri Rozovski, MD
Department of Cardiology
Tel Aviv Sourasky Medical Center
Tel Aviv
Israel
Declarações
UR declares that he has no competing interests.
David A. Garcia, MD
Professor
Division of Hematology
University of Washington Seattle
WA
利益声明
DAG declares that he has no competing interests.
Bethany Samuelson, MD
Fellow
Division of Hematology
University of Washington
Seattle
WA
利益声明
BS declares that she has no competing interests.
鉴别诊断
- Secondary (reactive) thrombocytosis
- Spurious thrombocytosis
- Familial essential thrombocythemia
更多 鉴别诊断指南
- NCCN clinical practice guidelines in oncology: myeloproliferative neoplasms
- The 5th edition of the World Health Organization (WHO) classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
更多 指南登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明